Clinical Trials

RECRUITING
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
This phase I/II trial studies the best dose, possible benefits and/or side effects of oral azacitidine in treating patients with T-cell large granular...
Conditions:
T-Cell Large Granular Lymphocyte Leukemia
Locations:
📍 Columbus, Ohio, United States
RECRUITING
Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
This phase II trial studies the effects of temozolomide and atezolizumab as second or third line treatment for patients with small cell lung cancer th...
Conditions:
Extensive Stage Lung Small Cell Carcinoma Metastatic Lung Small Cell Carcinoma Recurrent Lung Small Cell Carcinoma Stage IV Lung Cancer AJCC v8
2 more conditions available...
Locations:
📍 Chicago, Illinois, United States
📍 Indianapolis, Indiana, United States
📍 Iowa City, Iowa, United States
📍 Columbus, Ohio, United States
1 more location available...
RECRUITING
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
The purpose of this research study is to find out how safe and effective is treating patients with locally advanced rectal cancer (LARC) with chemothe...
Conditions:
Locally Advanced Rectal Cancer
Locations:
📍 Miami, Florida, United States
RECRUITING
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
This phase II trial investigates how well duloxetine and neurofeedback training work in treating patients with chemotherapy induced peripheral neuropa...
Conditions:
Chemotherapy-Induced Peripheral Neuropathy Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm
Locations:
📍 Houston, Texas, United States
📍 Houston, Texas, United States
RECRUITING
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.
The purpose of this study is to evaluate if the combination of nivolumab and a CCR2/CCR5 dual antagonist (BMS-813160) with GVAX is safe in patients wi...
Conditions:
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC) Pancreatic Ductal Adenocarcinoma
Locations:
📍 Baltimore, Maryland, United States
RECRUITING
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's cho...
Conditions:
Non-Muscle Invasive Bladder Cancer
Locations:
📍 Little Rock, Arkansas, United States
📍 Los Alamitos, California, United States
📍 San Diego, California, United States
📍 Sherman Oaks, California, United States
42 more locations available...
RECRUITING
Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors
A 12 weeks technology enhanced home exercise (TEHE) program using mobile technologies that provide immediate feedback and send reminder messages to im...
Conditions:
Cancer-related Problem/Condition Exercise Acupressure
Locations:
📍 Baltimore, Maryland, United States
NOT_YET_RECRUITING
Remote Temperature Monitoring of Adult Subjects Undergoing Outpatient Stem Cell Transplant or CAR-T Cell Therapy
IDION is currently seeking FDA approval for this device- the IDION iTempShield. It is a skin-safe, FDA complaint and non-invasive device that can read...
Conditions:
Febrile Neutropenia
Locations:
📍 Charleston, South Carolina, United States
RECRUITING
Focused Ultrasound and Gemcitabine in Breast Cancer
This study will test the use of focused ultrasound ablation, low-dose gemcitabine (a chemotherapy) and the combination of focused ultrasound ablation ...
Conditions:
Breast Cancer Breast Neoplasms
Locations:
📍 Charlottesville, Virginia, United States
RECRUITING
Music Therapy at TMH Infusion Center
The goal of this clinical trial is to test the effects of a listening music intervention on the symptom burden carried by patients who are receiving i...
Conditions:
Music Therapy
Locations:
📍 Providence, Rhode Island, United States
RECRUITING
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
This is a Phase III open-label study to assess if camizestrant improves outcomes compared to standard adjuvant endocrine therapy for patients with ER+...
Conditions:
Breast Cancer, Early Breast Cancer
Locations:
📍 Phoenix, Arizona, United States
📍 Fayetteville, Arkansas, United States
📍 Duarte, California, United States
📍 Fountain Valley, California, United States
632 more locations available...
RECRUITING
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
BACKGROUND: * Primary CNS lymphoma (PCNSL) is a rare subtype of diffuse large B-cell lymphoma. * The outcome for patients with this diagnosis is sign...
Conditions:
Primary Central Nervous System Lymphoma
Locations:
📍 Bethesda, Maryland, United States
NOT_YET_RECRUITING
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
This phase II trial tests how well gemcitabine, cisplatin and nab-paclitaxel given before surgery (neoadjuvant) works in treating patients with pancre...
Conditions:
Borderline Resectable Pancreatic Ductal Adenocarcinoma Resectable Pancreatic Adenocarcinoma Stage I Pancreatic Cancer AJCC v8 Stage II Pancreatic Cancer AJCC v8
1 more condition available...
Locations:
📍 Atlanta, Georgia, United States
RECRUITING
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
The purpose of this study is to assess the efficacy and safety of oral azacitidine plus best supportive care versus best supportive care as maintenanc...
Conditions:
Acute Myeloid Leukemia
Locations:
📍 Huntsville, Alabama, United States
📍 Nagoya, Aichi, Japan
📍 Toyoake, Aichi, Japan
📍 Kamogawa, Chiba, Japan
27 more locations available...
RECRUITING
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
This is a Phase III, randomized, open-label, multicenter, global study to compare the efficacy and safety of Datopotamab Deruxtecan (Dato-DXd) in comb...
Conditions:
NSCLC
Locations:
📍 Phoenix, Arizona, United States
📍 Tucson, Arizona, United States
📍 Hot Springs National Park, Arkansas, United States
📍 Little Rock, Arkansas, United States
303 more locations available...

Total Trials: 31 - 45 of 1271